Method for the detection of human hematopoietic short term repopulating cells
CA 2428107 A1 · Owner: Eaves, Connie J. · Inventors: Glimm, Hanno; Eaves, Connie J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Two novel populations of human short term repopulating cells are described. In particular, The inventors have shown that sublethally irradiated NOD/SCID-b2M- /- mice allow the efficient engraftment of two previously undescribed populations of human short term repopulating cells (STRC) that do not produce detectable progeny in the more widely used NOD/SCID mouse. These novel cells are designated short term repopulating cells - myeloid (STRC-M) and short term repopulating cells - lympho-myeloid (STRC-ML) to reflect their different lineage potentials. The invention includes an assay for detecting STRC-M and STRC-ML which is useful in a wide range of applications including assessing of …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 7, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 7, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 7, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.